SII’s Covovax Receives Emergency Use Approval for Adults, Children Over 12
The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India’s (SII) Covid-19 ...
The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India’s (SII) Covid-19 ...
Covid-19 vaccine Covaxin manufacturer Bharat Biotech has submitted the trial data for children in the 2-18 years age group to ...
The single-dose COVID-19 vaccine Sputnik Light received approval from the Subject Expert Committee (SEC) of the Drugs Controller General of ...
The Drugs Controller General of India (DCGI) approved a study on mixing Covaxin and Covishield Covid-19 vaccines in India on ...
The pace of the second wave of coronavirus in the country is now slowing down. The country is being vaccinated ...
Bharat Biotech has submitted phase 3 data to the Drug Controller General of India (DCGI) for their indigenous Covid-19 vaccine, ...
Trial of Bharat Biotech's Covaxin in the 2-18 years age group is likely to begin in the next 10-12 days. ...
After the adverse effect of Oxford's much-anticipated vaccine being developed with UK firm AstraZeneca, the clinical trials across the world ...